Divergent Effects of T Cell Costimulation and Inflammatory Cytokine Production on Autoimmune Peripheral Neuropathy Provoked by Aire Deficiency by Zeng, Xiaopei L. et al.
Divergent effects of T cell costimulation and inflammatory
cytokine production on autoimmune peripheral neuropathy
provoked by Aire deficiency
Xiaopei L. Zeng*,‡, Anil Nagavalli*,‡, Colin-Jamal Smith*, James F. Howard†, and Maureen A.
Su*
*Department of Pediatrics, Department of Microbiology and Immunology, School of Medicine,
University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
†Department of Neurology, School of Medicine, University of North Carolina at Chapel Hill,
Chapel Hill, NC 27599
Abstract
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) results from autoimmune
destruction of the peripheral nervous system (PNS) and is a component of the multi-organ
autoimmunity syndrome which results from Autoimmune Regulator (Aire) gene mutations in
humans. In parallel, PNS autoimmunity resembling CIDP develops spontaneously in NOD mice
with a partial loss of Aire function (NOD.AireGW/+ mice), and is a T cell-mediated disease. In this
study, we analyze how key aspects of T cell activation and function modulate disease development
in Aire-deficient mice. We show here that genetic ablation of the Th1 cytokine IFNγ completely
prevents clinical and electrophysiological evidence of neuropathy in NOD.AireGW/+ mice. IFNγ
deficiency is associated with absence of immune infiltration and decreased expression of the T cell
chemoattractant IP-10 in sciatic nerves. Thus, IFNγ is absolutely required for the development of
autoimmune peripheral neuropathy in NOD.AireGW/+ mice. Because IFNγ secretion is enhanced
by B7-CD28 costimulation of T cells, we sought to determine the effects of these costimulatory
molecules on neuropathy development. Surprisingly, B7-2 deficiency accelerated neuropathy
development in NOD.AireGW/+ mice, and antibody blockade of both B7-1 and B7-2 resulted in
fulminant, early-onset neuropathy. Thus, in contrast to IFNγ, B7-2 alone and B7-1/B7-2 in
combination function to ameliorate neuropathy development in NOD.AireGW/+ mice. Together,
these findings reveal distinct and opposing effects of T cell costimulatory pathways and IFNγ
production on the pathogenesis of autoimmune peripheral neuropathy.
INTRODUCTION
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is characterized by long-term
sensory and motor dysfunction resulting from autoimmune attack of the peripheral nerve
system (PNS) (1). Two reports of CIDP in unrelated patients with Autoimmune
Polyendocrinopathy Syndrome type 1 (APS1), a disorder linked to mutations in the
autoimmune regulator (Aire) gene, suggest a relationship between Aire and CIDP (2, 3). In
addition, we recently showed that a strain of NOD mice with a dominant G228W mutation
(NOD.AireGW/+ mice) develops spontaneous autoimmune peripheral neuropathy resembling
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CIDP (4, 5). Thus, Aire dysfunction has been linked to PNS autoimmunity in both mice and
humans.
In the thymus, Aire promotes ectopic expression of peripheral tissue antigens, which
mediates the negative selection of self-reactive thymocytes (6, 7). The dominant G228W
mutation results in partial loss of Aire function, reducing expression levels of self-antigens
to ~10% of wildtype levels (5). This decreased expression allows escape of self-antigen-
recognizing T cells from thymic negative selection, which predisposes to autoimmune
disease. A major self-antigen recognized by T cells in NOD.AireGW/+ mice and APS1
patients with autoimmune peripheral neuropathy is myelin protein zero (P0), a PNS-specific
protein (4). NOD.AireGW/+ mice express P0 in the thymus at greatly reduced levels,
suggesting that ectopic P0 expression in the thymus is Aire-regulated (5). Consistent with a
defect in the negative selection of P0-specific T cells, increased peripheral T cell responses
to P0 are seen in NOD.AireGW/+ mice (4).
The role of Aire in T cell negative selection suggests that T cell dysregulation underlies the
PNS autoimmunity in Aire-deficiency. In addition, there is ample evidence that T cell
dysregulation is a key component of PNS autoimmunity. For instance, in experimental
allergic neuritis (EAN), an induced model of inflammatory demyelinating disease of the
PNS, T cell-deficient mice are clinically and histologically unaffected by EAN compared to
wild type mice (8). Also, in spontaneous models of PNS autoimmunity, T cells are sufficient
to transfer neuropathy to immunodeficient recipients (4, 9). Although the evidence for an
important role of T cells in PNS autoimmunity is strong, how T cell costimulation impinges
on PNS-specific T cells and how T cell inflammatory cytokine production directs
neuropathy development require further clarification.
In addition to engagement of the T cell receptor by antigen and major histocompatibility
complex (MHC) on the antigen-presenting cell (APC), costimulation is necessary for either
the activation of naïve T cells or immunoregulation in different disease settings. A
prominent costimulatory interaction is between CD28 on CD4+ T cells and B7-1/B7-2
(CD80/CD86) on APCs (10, 11). In certain autoimmune diseases, this interaction promotes
autoimmune disease development. For instance, in the adoptive transfer model of
experimental autoimmune encephalitis (EAE), blocking costimulation attenuates clinical
outcomes of disease (12) and genetic ablation of CD28 or B7-1/B7-2 confers resistance to
disease (13). Also, CD28 deficiency prevents the development of neuropathy in EAN,
suggesting a pathogenic role for this costimulatory pathway in autoimmune peripheral
neuropathy (14). In addition to a pro-inflammatory role, this costimulatory interaction can
also dampen autoimmune disease development. For example, the same deficiencies of B7-1/
B7-2 and CD28 in NOD mice cause an accelerated development of autoimmune diabetes
(15). Interestingly, the ablation of only B7-2 redirects autoimmunity from the pancreas to
the peripheral nerves in NOD mice (9). Thus, the way in which B7-1/B7-2 costimulation of
T cells affects autoimmune disease development is not straightforward.
B7-CD28 costimulation of T cells has multiple effects on naïve T cells, including the
modulation of T cell inflammatory cytokine production. CD28 stimulation acts through the
AKT intracellular signaling pathway to increase production of IFNγ (16, 17) and enhances
IFNγ promoter activity by 3–6 fold (18). At the same time, T cells from NOD mice
deficient in B7-1/B7-2 and T cells from EAN mice deficient in CD28 demonstrate decreased
IFNγ production (14, 15). IFNγ production, then, in these two autoimmune disease settings
is promoted by T cell costimulatory activity.
Whether IFNγ exacerbates or protects from autoimmune peripheral neuropathy
development is contentious. On the one hand, IFNγ has been reported to be required for
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development of autoimmune peripheral neuropathy in both induced and spontaneous models
of autoimmune peripheral neuropathy (19–21). Conversely, Zhang et al. recently reported
that IFNγ deficient mice developed exacerbated clinical symptoms of EAN, indicating a
protective function of IFNγ (22). Although inconsistent with previous reports in
autoimmune peripheral neuropathy, this protective role of IFNγ falls in line with evidence
from other autoimmune diseases that are aggravated in the absence of IFNγ, such as EAE
(23), collagen induced arthritis (24), and rheumatoid arthritis (25).
In this study, we focus on delineating how T cell IFNγ production and B7-CD28
costimulation affect development of spontaneous autoimmune peripheral neuropathy in
NOD.AireGW/+ mice. We demonstrate that genetic ablation of IFNγ prevents clinical,
histological, and electrophysiological evidence of neuropathy in NOD.AireGW/+ mice,
which indicates that IFNγ is absolutely required for disease development. In contrast,
deficiency of B7-2 alone and blockade of B7-1/B7-2 in combination significantly
accelerates neuropathy development, pointing to a protective role for T cell costimulation in
this model. Together, these results suggest that IFNγ production and B7-CD28
costimulatory pathways have distinct and potentially opposing effects on T cells in the
development of autoimmune peripheral neuropathy.
MATERIALS AND METHODS
Mice
NOD.AireGW/+ mice were generated as previously described (5). NOD.IFNγ−/− mice are
from the Type-1 Diabetes Mouse Resource (Jackson Laboratory). Because Aire and IFNγ
are both on chromosome 10, NOD.AireGW/+IFNγ−/− mice were generated from a founder
mouse with crossover between these two loci. The line was continued by maintaining the
mutant IFNγ locus in the homozygous state. NOD.B7-2−/− mice (9) were a gift from Dr.
Jeffrey Bluestone. Mice in these experiments were backcrossed into the NOD/ShiLtJ
background for greater than 10 generations. NOD.scid mice were purchased from the
Jackson Laboratory. Mice were housed in a pathogen free barrier facility at University of
California, San Francisco (UCSF) and University of North Carolina Chapel Hill (UNC
Chapel Hill).
Animals were assessed for clinical neuropathy and diabetes as described in (4). Mice were
assessed at least once per week. Experiments complied with the Animal Welfare Act and the
National Institute of Health (NIH) guidelines for the ethical care and use of animals in
biomedical research.
Histology
Harvested organs were fixed in 10% formalin overnight, changed into 30% ethanol for 30
minutes, and then stored in 70% ethanol. Organs were embedded in paraffin, sectioned and
stained with Hematoxylin/Eosin. Immune infiltration was scored in a blinded fashion using a
system that has been previously described (5). 0, 1, 2, 3, 4 scores indicate 0%, 25%, 25–
50%, 50–75%, and >75% infiltration respectively.
Intracellular Cytokine Staining
Intracellular cytokine staining and flow cytometry were performed as described in (26).
Splenocytes were stained with anti-CD3 and anti-IFNγ antibodies and analyzed on a Cyan
ADP Analyzer (Beckman Coulter).
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Stains for immune cells in OCT-embedded sciatic nerves were performed with anti-CD4
(BioXcell, GK1.5) and anti-F4/80 (eBioscience BM8) antibodies as described in (26). Stains
for IP-10 were performed with anti-IP-10 antibody (R&D systems) as described in (27).
Electrophysiology
Sciatic nerve conduction studies were performed as described in (28) using a Teca Synergy
EMG system.
Adoptive Transfer
Adoptive transfer of CD4+ T cells from spleen and lymph nodes of female neuropathic
NOD.AireGW/+ mice or age-matched IFNγ-deficient NOD.AireGW/+ mice were performed
as described in (4). CD4+ T cells were isolated using anti-CD4 microbeads (Miltenyi
Biotec) on a MS or LS column. CD4+ T cells were activated in the presence of anti-CD3
and anti-CD28 (1 microgram per mL in PBS) for 96 hours. 7×106 CD4 T cells were
transferred retro-orbitally into female NOD.scid recipients
Antibody treatment
Anti-B7-1 antibody (clone 16.10A1) and anti-B7-2 (clone GL1) were generous gifts of Greg
Szot (UCSF) or purchased from the UCSF Hybridoma Core. 14 day old mice were treated
with 50 micrograms of antibody or isotype control every other day for 10 treatments. For
flow cytometry analysis of Tregs, mice were sacrificed 8 days after last treatment.
Foxp3 staining
Thymocytes and lymphocytes were prepared for flow analysis as previously described in
(26). Cells were stained according to manufacturer instructions (eBiosciences) with
fluorochrome-labeled antibody specific for mouse CD4 (clone RM4-5), CD8a (clone 53–
6.7), CD25 (clone PC61.5), and Foxp3 (clone FJK-16a).
Real Time RT-PCR
Fresh sciatic nerves were placed immediately into cell lysis buffer, and mRNA isolated with
RNeasy Miniprep Kit (Qiagen). SuperScript VILO cDNA Synthesis Kit (Invitrogen) and
TaqMan Universal PCR Master Mix (Applied Biosystems) were used for cDNA synthesis
and PCR, respectively. Commercially available TaqMan primer-probe set (Applied
Biosystems) for CXCL10 was used. Cyclophilin A was used as an internal control and
detected with the primer-probe set reported in (5). Reactions were run on the ABI 7900HT
Fast Real-Time PCR System (Applied Biosystems) and analyzed as in (5).
Statistics
Data was analyzed with Prism software (GraphPad) using unpaired t-tests. Log rank tests
were used for comparison of survival curves. p≤0.05 was considered significant.
RESULTS
IFNγ is required for development of spontaneous autoimmune peripheral neuropathy in
NOD.AireGW/+ mice
The specific cytokines critical for the pathogenesis of autoimmune peripheral neuropathy are
not clear. Multiple cytokines, including IFNγ, IL-17, and TNFα have been implicated in
disease development (20, 22, 29–32). In NOD.AireGW/+ mice, IFNγ is a predominant
cytokine produced by sciatic nerve infiltrating CD4+ T cells (4). However, whether IFNγ
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production is required for development of autoimmune peripheral neuropathy in
NOD.AireGW/+ mice is not known. To test this, we genetically ablated IFNγ from
NOD.AireGW/+ mice to produce doubly deficient NOD.AireGW/+IFNγ−/− mice. Lack of
IFNγ production by T cells in these mice was confirmed by intracellular IFNγ staining and
flow cytometry of CD3+ splenocytes (Fig 1A). To determine the effect of IFNγ deficiency
on the development of neuropathy, we monitored a female cohort of NOD.AireGW/+IFNγ−/−
mice and NOD.AireGW/+IFNγ+/− or +/+ controls for a total of 38 weeks. Consistent with our
previous reports, 80% of IFNγ-sufficient NOD.AireGW/+ mice developed neuropathy by 22
weeks of age (Fig 1B) (4). Strikingly, however, none of the IFNγ-deficient NOD.AireGW/+
mice developed clinical signs of neuropathy. Protection from clinical neuropathy was
associated with absence of cellular immune infiltration within the sciatic nerves on H/E
staining (Fig 1C, D). We have previously reported that the immune infiltrates found in
sciatic nerves of NOD.AireGW/+ mice predominantly consists of CD4+ T cells and F4/80+
macrophages (4). Minimal CD4 and F4/80 expression could be detected by
immunohistochemical staining within the sciatic nerves of IFNγ-deficient NOD.AireGW/+
mice (Fig 1E). Together, these data clearly demonstrate that IFNγ is necessary for the
development of autoimmune peripheral neuropathy in NOD.AireGW/+ mice.
In addition to neuropathy, NOD.AireGW/+ mice also develop additional autoimmune
manifestations, including diabetes and sialitis (5), allowing us to simultaneously access the
role of IFNγ in the development of these multiple autoimmune manifestations. In contrast to
neuropathy, autoimmune diabetes developed at the same incidence in IFNγ-deficient
NOD.AireGW/+ mice as in IFNγ-sufficient NOD.AireGW/+ controls (Fig 1F). In addition,
severity of insulitis within the pancreas was unchanged regardless of IFNγ status (Supp. Fig
1A, B). Therefore, IFNγ is dispensable for the development of autoimmune diabetes in
NOD.AireGW/+ mice. This finding is consistent with reports that genetic deficiency of IFNγ
or IFNγ receptor in NOD.WT mice does not significantly affect diabetes incidence (33–36).
Furthermore, no changes in the development of sialitis, dacroadenitis, or uveitis were
detected by histological analysis in IFNγ-deficient versus IFNγ-sufficient NOD.AireGW/+
mice (Supp. Fig 1C and not shown). Thus, among the autoimmune manifestations in
NOD.AireGW/+ mice, autoimmune peripheral neuropathy appears to be uniquely dependent
on IFNγ.
Lack of IFNγ prevents development of electrophysiological abnormalities on nerve
conduction studies in NOD.AireGW/+ mice
Nerve conduction studies of CIDP patients demonstrate characteristic findings of chronic
demyelination (37). These abnormalities include slowed conduction velocity and dispersion
of compound muscle action potentials. To determine whether autoimmune peripheral
neuropathy in NOD.AireGW/+ mice results in electrophysiological changes, we performed
nerve conduction studies, as described in (28), on the sciatic nerves of >15 week old
neuropathic NOD.AireGW/+ mice and age-matched IFNγ-deficient NOD.AireGW/+ mice.
Studies on neuropathic NOD.AireGW/+ mice demonstrated abnormalities indicative of
predominantly demyelinating neuropathy, including reduced amplitude, slowed conduction
velocity, and increased duration (Fig 2A, B, and D). In contrast, NOD.AireGW/+IFNγ−/−
sciatic nerves were indistinguishable from wildtype sciatic nerves (Fig 2C and D). IFNγ-
deficiency, therefore, prevents the development of the electrophysiological abnormalities
seen in NOD.AireGW/+ sciatic nerves.
Lack of IFNγ production by CD4+ T cells from NOD.AireGW/+ mice prevents transfer of
peripheral neuropathy
IFNγ is produced mainly by T cells and natural killer (NK) cells. We have previously
shown that CD4+ T cells from neuropathic NOD.AireGW/+ mice are sufficient to transfer
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neuropathy to immunodeficient SCID mice on the NOD background (NOD.scid) (4). To
determine whether IFNγ production by CD4+ T cells is necessary for neuropathy transfer,
we performed adoptive transfer experiments with CD4+ cells from >20 week old
NOD.AireGW/+ IFNγ−/− females into NOD.scid females. In this setting, IFNγ production
was lacking in T cells, but present in NK cells of reconstituted mice. None of the recipients
of IFNγ-deficient CD4+ T cells developed neuropathy even 12 weeks post transfer, while
all recipients of IFNγ-sufficient CD4+ T cells developed neuropathy by 6 weeks post
transfer (Fig 3A). Consistent with this finding, dense immune infiltrates were seen on
histologic sections of all sciatic nerves from recipients of IFNγ producing CD4+ T cells,
whereas no immune infiltration was seen in any of the sciatic nerves from recipients of
IFNγ-deficient CD4+ T cells (Fig 3B,C). Thus, lack of IFNγ production by CD4+ T cells
prevents transfer of neuropathy.
Decreased IP-10 expression in sciatic nerves of NOD.AireGW/+ mice lacking IFNγ
IFNγ has a variety of effects on the immune response (38–41), one of which is the induction
of chemokines required for immune cell targeting to tissues (42–44). Of particular interest is
the IFNγ-inducible chemokine CXCL10/interferon-inducible protein-10 (IP-10), which is
highly expressed on endoneurial endothelial cells in inflammatory demyelinating
neuropathies (45, 46). Additionally, increased expression of IP-10 in nerves is associated
with CIDP in humans (46) and with clinical neuropathy in NOD.AireGW/+ mice (4). IP-10
promotes the transendothelial migration of macrophages and activated CD4+ T cells to sites
of inflammation by binding to its receptor CXCR3 expressed on these immune cells (47–
49). In an EAE model, blocking IP-10 reduced the accumulation of immune cells within the
central nervous system while increasing absolute splenocyte counts (47). In NOD.AireGW/+
mice, we also observed increased total splenocyte (Fig 4A) and CD4+ T cell (Fig 4B)
numbers in the setting of decreased immune infiltration within the sciatic nerves (Fig 1C, E).
These similarities led us to hypothesize that IFNγ-deficiency in NOD.AireGW/+ mice may
be associated with reduced IP-10 expression in sciatic nerves.
To test this hypothesis, we analyzed the relative expression of IP-10 in the sciatic nerves of
neuropathic NOD.AireGW/+ mice versus age-matched IFNγ-deficient NOD.AireGW/+ mice.
Immunohistochemical staining of sciatic nerves showed abundant IP-10 within the sciatic
nerves of neuropathic NOD.AireGW/+ and decreased IP-10 within the sciatic nerves of age-
matched IFNγ-deficient NOD.AireGW/+ mice (Fig 4C). Consistent with this finding, real
time RT-PCR analysis of IP-10 mRNA expression in the sciatic nerve demonstrated
increased expression in neuropathic NOD.AireGW/+ mice compared to age-matched IFNγ-
deficient NOD.AireGW/+ mice (Fig 4D). As expected from our previously published data
(4), IP-10 expression was low in young NOD.AireGW/+ and young NOD.AireGW/+IFNγ−/−
mice. Increased IP-10 was not merely a baseline feature of the NOD strain, since aged
IFNγ-sufficient NOD.Aire+/+ mice did not demonstrate increased IP-10 levels (Fig 4D).
Interestingly, the IP-10 expression of aged NOD.AireGW/+IFNγ−/− mice was not zero,
suggesting a basal level expression that is not dependent on IFNγ. This is consistent with
studies showing other factors including IFNα, IFNβ, and LPS to also induce IP-10
expression (42–44).
Blockade of B7-1/B7-2 in NOD.AireGW/+ mice results in fulminant, early-onset autoimmune
peripheral neuropathy
Previous work has demonstrated that T cell IFNγ production is controlled in part by B7-1/
B7-2 costimulation of T cells. In NOD mice, genetic ablation of both B7-1 and B7-2
resulted in decreased T cell IFNγ production (15). Given our finding that IFNγ is absolutely
required for neuropathy development, we sought to determine the effect of B7-1 and B7-2
blockade on neuropathy development in NOD.AireGW/+ mice. Surprisingly, treatment of
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NOD.AireGW/+ mice between 2–4 weeks of age with anti-B7-1 and -B7-2 antibodies
resulted in fulminant early onset neuropathy (Fig 5A). NOD.AireGW/+ mice became
neuropathic at 8 weeks of age and 100% of mice were neuropathic by 11 weeks. Treatment
with anti-B7-1/B7-2 antibody accelerated neuropathy to a greater degree in NOD.AireGW/+
mice than in wildtype mice suggesting an additive effect of Aire deficiency and lack of
costimulation in the development of autoimmune peripheral neuropathy. Manifestation of
neuropathy was associated with severe immune infiltration of sciatic nerves (Fig 5B, C).
Thus, despite decreased IFNγ production in NOD mice lacking B7-1/B7-2 (15), blockade of
B7-CD28 costimulation accelerated neuropathy development in NOD.AireGW/+ mice.
In addition to assessing neuropathy, we simultaneously monitored diabetes development in
anti-B7-1/B7-2 antibody treated mice. Genetic ablation of B7-1 and B7-2 in a mixed NOD-
C57BL/6 strain has been shown to result in early onset autoimmune diabetes (15).
Consistent with this finding, treatment of wildtype NOD mice with anti-B7-1 and anti-B7-2
antibodies resulted in early onset autoimmune diabetes (Supp. Fig 2), as previously reported
(50). In contrast, diabetes was not seen in any NOD.AireGW/+ mice treated with anti-B7-1
and -2 antibodies. Thus, B7-1 and B7-2 blockade specifically accelerates neuropathy
development without accelerating diabetes development in NOD.AireGW/+ mice.
Blockade of B7-1/B7-2 in NOD.AireGW/+ mice is associated with decreased regulatory T
cells
B7-CD28 costimulaton is required for the development and peripheral maintenance of
CD4+CD25+ regulatory T cells (Tregs) (15, 51, 52). Treg population size has been reported
to be reduced by as much as 80% in NOD mice deficient in B7-1/B7-2 (10) and CD28 (15).
We therefore hypothesized that the acceleration of neuropathy seen in NOD.AireGW/+ mice
in the setting of B7-1 and B7-2 costimulation blockade may reflect a dependence on Tregs
to delay neuropathy onset in NOD.AireGW/+ mice.
To test this possibility, NOD.AireGW/+ mice were treated with anti-B7-1/2 antibodies and
Treg levels were measured one week after the treatment course. Similar to NOD.WT mice,
NOD.AireGW/+ mice treated with anti-B7-1/2 antibodies demonstrated significantly
decreased frequencies of Tregs in both the thymus and spleen compared to the isotype
control treated groups (Fig 6A and B). These findings suggest that the anti-B7-1/2 antibody
effect on Treg frequency is not dependent on the presence of Aire. Additionally, the absolute
number of Tregs in the thymus was significantly reduced in the anti-B7-1/2 antibody treated
AireGW/+ group (Fig 6C). In the spleen, there was ~70% decrease in absolute numbers of
Tregs in both the anti-B7-1/2 antibody treated NOD.WT and NOD.AireGW/+ groups (Fig
6C).
Although previous reports of Tregs in Aire-deficient mice indicate no change in Treg
numbers (6, 7, 53, 54), Lei et al. recently reported that that Aire-deficient mice have a
reduction in the number of thymic Tregs (55). Consistent with this latter report, we also
noticed a decrease in the absolute numbers of Tregs in the thymus of isotype control treated
NOD.AireGW/+ mice compared to NOD.WT mice (Fig 6C). To investigate this further, we
compared Treg numbers in untreated 8-week-old NOD.WT and NOD.AireGW/+ mice. Treg
numbers were significantly lower in untreated NOD.AireGW/+ thymi compared to NOD.WT
thymi (Fig 6D). Thus, in line with the report of Lei et al, NOD.AireGW/+ mice demonstrate
decreased numbers of thymic Tregs.
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B7-2 deficiency and loss of Aire function have additive effects on the development of
peripheral neuropathy
By itself, B7-2 deficiency in NOD mice (NOD.B7-2−/− mice) protects against autoimmune
diabetes but redirects the autoimmune response toward the PNS (9). Lack of B7-2 may
promote neuropathy development by upregulating B7-1 expression on CD11b+ and CD11c+
antigen presenting cells within sciatic nerves (9). Onset of spontaneous neuropathy in
NOD.B7-2−/− mice occurs approximately 7–10 weeks later than in NOD.AireGW/+ mice. To
determine how B7-2 deficiency alone impinges on Aire-mediated spontaneous neuropathy
development, we crossed NOD.B7-2−/− mice with NOD.AireGW/+ mice to create NOD mice
doubly deficient for Aire and B7-2. These mice developed neuropathy at an accelerated rate
compared to singly Aire-deficient controls, with 100% of mice developing neuropathy by 19
weeks of age (Fig 7A, B). This effect was more pronounced in male mice (Fig 7B) than in
female mice (Fig 7A) although the differences were significant in both genders. Neuropathy
was associated with sciatic nerve infiltration on histological analysis (Fig 7C, D).
NOD.AireGW/+ mice treated with an anti-B7-2 blocking antibody (GL-1) also displayed
accelerated clinical neuropathy compared with those treated with isotype control (data not
shown). The additive effects of these two immune tolerance defects suggest that Aire and
B7-2 may function in two distinct pathways to prevent the development of autoimmune
peripheral neuropathy.
DISCUSSION
Autoimmune peripheral neuropathy in NOD.AireGW/+ mice shares a number of features
with human CIDP, including demyelination of peripheral nerves, immune infiltration
consisting largely of CD4+ T cells and macrophages, and the clinical manifestation of
chronic, bilaterally-symmetrical weakness (4). Although the exact mechanism underlying
autoimmune peripheral neuropathy is not fully understood, there is strong evidence for a
critical role of T cells in disease development. Thus, understanding T cell activation and
function in autoimmune peripheral neuropathy is key to understanding pathogenesis. In this
study, we examine the roles of T cell inflammatory cytokine production and B7-CD28
costimulatory pathway in the development of autoimmune peripheral neuropathy. We show
that IFNγ is indispensable for immune infiltration of peripheral nerves and clinical
neuropathy development in NOD.AireGW/+ mice. Furthermore, transfer of disease by CD4+
T cells requires IFNγ production by T cells. On the other hand, T cell costimulation by
either B7-2 alone or B7-1/B7-2 in combination has immunoregulatory effects in
autoimmune peripheral neuropathy as indicated by the acceleration of autoimmune
peripheral neuropathy in NOD.AireGW/+ mice lacking these costimulatory signals. Thus,
despite evidence that pathogenic IFNγ production is controlled in part by B7-1/B7-2
costimulatory signaling, IFNγ production and B7-CD28 costimulation have opposing
effects on the development of autoimmune peripheral neuropathy.
Levels of inflammatory cytokines have been correlated with active disease in CIDP patients
and animal models (32, 56). The precise role of individual cytokines, however, is not clear.
A critical role for Th1 cytokines has been demonstrated in both induced and spontaneous
mouse models by delayed onset and reduced severity of neuropathy in mice deficient for
IFNγ receptor (19), IFNγ (20, 57), and TNFα (30). At the same time, other reports suggest
that the Th17 cytokine IL-17 production, and not IFNγ production, is important in disease
pathogenesis. Increased IL-17 production has been associated with exacerbated EAN in the
setting of IFNγ deficiency (22) and is the predominant cytokine in a spontaneous ICAM-1
deficient model of neuropathy (31). Our study clearly shows that IFNγ is required for the
development of autoimmune peripheral neuropathy in Aire-deficient NOD mice. The lack of
neuropathy in IFNγ-deficient mice suggests that IL-17 cannot substitute for IFNγ in this
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model. Differences between our findings and other reports identifying IL-17 as a critical
cytokine may lie in the differences inherent to the models used in these studies.
Chemokines play an important role in immune cell trafficking, and IFNγ induces the
production of a variety of chemokines, including IP-10 and RANTES (49, 58). Importantly,
mice deficient in the RANTES receptor CCR5 are not protected from EAN (27), whereas
IP-10-deficient mice are protected from demyelination and inflammatory cell infiltration
(59). Together, these findings suggest a critical role for IP-10, and not RANTES, in EAN
development. Consistent with this, we show here that IP-10 levels were significantly
reduced in the sciatic nerves of IFNγ-deficient NOD.AireGW/+ mice compared to age-
matched, neuropathic NOD.AireGW/+ mice. Taken together, these data suggest that the lack
of IP-10 in IFNγ-deficient NOD.AireGW/+ mice may prevent immune infiltration of the
sciatic nerves.
Absence of CD28 signaling confers protection from EAN development (14). On the other
hand, NOD mice deficient in B7-2 are protected from diabetes but develop spontaneous
autoimmune peripheral neuropathy (9). Thus, there is evidence that B7-CD28 costimulation
have both a pathogenic and protective effect in autoimmune peripheral neuropathy. Here we
show that lack of B7-1 and B7-2 accelerates disease, indicating a protective effect for B7-
CD28 costimulation signaling in NOD.AireGW/+ mice. This protective effect may be
mediated by the promotion of Treg development by B7-1/2 signaling since significantly
decreased Tregs were observed in anti-B7-1/2 antibody treated NOD.AireGW/+ mice
compared to isotype control treated NOD.AireGW/+ mice. Moreover, the decrease in Tregs
seen in NOD.AireGW/+ compared to NOD.WT mice suggests that the more severe pathology
observed in anti-B7-1/2 antibody treated NOD.AireGW/+ mice compared to anti-B7-1/2
antibody treated NOD.WT mice may be a result of the combined action on Tregs by
costimulation blockade and Aire deficiency. In addition to its effects on Tregs, another
possible mechanism by which blockade of B7-1/2 costimulation may accelerate neuropathy
is by altering clonal deletion of autoreactive T cells in the thymus. Although some studies
have not revealed a role for B7-1/2 costimulation in thymic negative selection (60–62),
others have shown that blocking B7/CD28 costimulation can result in the accumulation of
self-reactive T cells in the thymus and that release of these T cells into the periphery can
contribute to autoimmune disease pathogenesis (63–67).
Multiple autoimmune diseases, including autoimmune neuropathy, diabetes, and sialitis
occur with high penetrance in NOD.AireGW/+ mice, which allows us the unique opportunity
to evaluate the effects of interventions on both diseases in parallel. Remarkably, the
development of these diseases appears to be differentially regulated by T cell IFNγ
production and costimulatory blockade. Our data demonstrate that although IFNγ
production is absolutely required for neuropathy development, it is dispensable for
autoimmune diabetes and sialitis development in NOD.AireGW/+ mice. This is in line with
evidence demonstrating IFNγ knockout (33) and IFNγR knockout (35, 36) NOD mice are
not protected from the development of autoimmune diabetes. Additionally, our data
demonstrate distinct effects of B7-CD28 costimulation on diabetes and neuropathy
development in NOD.AireGW/+ mice. Whereas lack of B7-1/B7-2 accelerates neuropathy
development in NOD.AireGW/+ mice, this deficiency does not accelerate diabetes
development in these same mice. Together, these findings suggest that the multiple
autoimmune manifestations in NOD.AireGW/+ mice appear to be governed by distinct
effector mechanisms.
Findings from this study have important implications for the potential treatment of patients
with multi-organ autoimmunity, including APS1 patients. Modulating specific aspects of T
cell function may have diverse effects on each individual autoimmune disease. For example,
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IFNγ blockade may have therapeutic efficacy in treating autoimmune peripheral
neuropathy, but is unlikely to have efficacy in other manifestations, such as sialitis. Indeed,
in a case report of an APS1 patient treated with the immunosuppressant cyclosporine A,
improvement in autoimmune gastrointestinal disease, keratoconjunctivitis, and alopecia
universalis was seen. However, cyclosporine A treatment did not have an effect on
autoimmune ovarian failure or adrenal disease (68). Furthermore, some treatments may have
opposite effects on different diseases. For instance, blockade of B7-2 in the B7-CD28
costimulatory pathway may ameliorate autoimmune diabetes, but may accelerate
autoimmune peripheral neuropathy development. Thus, the distinct and potentially opposing
effects of T cell immunomodulatory agents on each individual affected organ need to be
considered when treating patients with multi-organ autoimmunity.
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Figure 1. IFNγ deficiency prevents neuropathy and neural infiltration, but not diabetes, in
NOD.AireGW/+ mice
A) Representative flow cytometry plots of CD3+ splenocytes from IFNγ-sufficient
(IFNγ+/+) and IFNγ-deficient (IFNγ−/−) NOD.AireGW/+ (AireGW/+) mice stained for
intracellular IFNγ. B) Neuropathy incidence curve of female IFNγ-sufficient
NOD.AireGW/+ (AireGW/+IFNγ+/+ or +/−, n=11) mice and IFNγ-deficient NOD.AireGW/+
mice (AireGW/+IFNγ−/−, n=13). C) Representative H/E stained, formalin fixed, longitudinal
sections of sciatic nerves from NOD wildtype (Aire+/+IFNγ+/+), NOD.AireGW/+
(AireGW/+IFNγ+/+), and IFNγ-deficient NOD.AireGW/+ (AireGW/+IFNγ−/−) mice (20×
magnification). D) Cumulative infiltration scores of sciatic nerves from IFNγ-sufficient and
IFNγ-deficient NOD.AireGW/+ mice. Each symbol represents an individual mouse. E)
Immunohistochemical stains of sciatic nerve from either neuropathic NOD.AireGW/+
(AireGW/+) mouse or age-matched IFNγ-deficient NOD.AireGW/+ for CD4 and F4/80.
Images shown are representative of 2 separate experiments. (20× magnification). F)
Diabetes incidence curve of female IFNγ-sufficient and IFNγ-deficient NOD.AireGW/+
mice. n.s.= not significant.
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Figure 2. IFNγ-deficiency protects NOD.AireGW/+ mice from abnormalities associated with
chronic demyelination on motor nerve electrophysiology
A–C) Representative distal and proximal compound muscle action potentials from the
sciatic nerve of age-matched wildtype (A), neuropathic IFNγ-sufficient NOD.AireGW/+ (B),
and age-matched IFNγ-deficient NOD.AireGW/+ (C) mouse. D) Mean amplitude,
conduction velocity, and duration of compound muscle action potentials from wildtype,
neuropathic IFNγ-sufficient NOD.AireGW/+ and age-matched IFNγ-deficient
NOD.AireGW/+ mice. * represents p<0.05. At least 3 mice were included in each group.
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Figure 3. IFNγ expression by CD4+ T cells is required for neuropathy transfer
A) Neuropathy incidence curve of NOD.scid mice receiving 7×106 CD4+ T cells from either
neuropathic IFNγ-sufficient NOD.AireGW/+ or age-matched IFNγ-deficient NOD.AireGW/+
mice. n=4 in each group. B) Representative H/E stained, formalin fixed, longitudinal
sections of sciatic nerve from recipient mice receiving CD4+ T cells from either IFNγ-
sufficient or IFNγ-deficient NOD.AireGW/+ mice at time of sacrifice. C) Infiltration scores
of sciatic nerves from recipient mice at the time of sacrifice. Each shape represents an
individual mouse.
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Figure 4. Decreased expression of IP-10 chemokine in sciatic nerves of IFNγ-deficient
NOD.AireGW/+ mice
A,B) Absolute number of total splenocytes (A) and CD4+ T cells (B) in NOD.AireGW/+
(n=3) and IFNγ-deficient NOD.AireGW/+ mice (n=6) as determined by flow cytometry. C)
Representative immunohistochemical stains of sciatic nerve from either neuropathic IFNγ-
sufficient or age-matched IFNγ-deficient NOD.AireGW/+ for IP-10. Images (20×
magnification) shown are representative of 2 separate experiments. D) Real-Time RT-PCR
assay for relative transcriptional expression of IP-10 (normalized to cyclophilin A) in sciatic
nerves of IFNγ-sufficient and IFNγ-deficient NOD.AireGW/+ mice at either >15 weeks of
age or <10 weeks of age and IFNγ-sufficient NOD.Aire+/+ mice at >15 weeks of age (n= 3
to 5 in each group). Data are from 2 separate experiments.
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Figure 5. Blockade of B7-1/B7-2 accelerates neuropathy development in NOD.AireGW/+ mice
A) Neuropathy incidence curve of NOD wildtype (Aire+/+) and NOD.AireGW/+ (AireGW/+)
mice treated with either isotype control or a combination of anti-B7-1 and B7-2 antibodies.
n=8 and n=7 for NOD wildtype mice treated with anti-B7-1/B7-2 antibodies and isotype
controls, respectively. n=5 and n=10 for NOD.AireGW/+ mice treated with anti-B7-1/B7-2
antibodies and isotype controls respectively. *p<0.007 for all curves compared to anti-B7-1
and B7-2 antibody treated NOD.AireGW/+ curve. B) Representative H/E stained, formalin
fixed, longitudinal section of sciatic nerve from anti-B7-1 and B7-2 antibody (Ab) treated
NOD.AireGW/+ mouse at time of sacrifice. Arrow points to a dense area of immune
infiltration. C) Cumulative infiltration scores of sciatic nerves from NOD wildtype (+/+) and
NOD.Aire GW/+ (GW/+) mice treated with either anti-B7-1/anti-B7-2 (B7-1/2) antibodies or
isotype (iso) control. Each symbol represents an individual mouse. *p<0.05 between groups.
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Figure 6. Decreased frequency and number of regulatory T cells (Tregs) with blockade of B7-1/2
in NOD.AireGW/+ mice
A) Representative flow cytometry plots of CD4+ single positive thymocytes and CD4+
splenocytes from anti-B7-1/2 antibody and isotype control antibody treated 4-week-old
NOD.WT (WT) and NOD.AireGW/+ (AireGW/+) mice stained for CD25 and intracellular
Foxp3. B) Frequency of CD4+CD25+Foxp3+ Tregs in the thymus and spleen of anti-B7-1/2
treated and isotype treated WT and AireGW/+ mice. n=3 to 4 for each group. Data is from 2
separate experiments. C) Absolute number of CD4+CD25+Foxp3+ Tregs from the thymus
and spleen of anti-B7-1/2 antibody treated and isotype control antibody treated WT and
AireGW/+ mice. D) Absolute numbers of CD4+CD25+Foxp3+ Tregs in thymus from
untreated 8-week-old WT (n=6) and AireGW/+ mice (n=6). Data from 2 separate
experiments. Significance indicated by *p<0.05, **p<0.01, ***p<0.001 between groups.
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Figure 7. Additive effect of B7-2 deficiency and Aire deficiency on the development of
neuropathy
A) Neuropathy incidence curve of female NOD wildtype (Aire+/+B7-2+/+; n=3),
NOD.AireGW/+ mice (AireGW/+B7-2+/+; n=5), NOD.B7-2−/− (Aire+/+B7-2−/−; n=4), or
doubly-deficient NOD.Aire GW/+ B7-2−/− (AireGW/+ B7-2−/−; n=8) mice. *p<0.05 for all
curves compared to NOD.AireGW/+ B7-2−/− curve. B) Neuropathy incidence curve of male
NOD wildtype (Aire+/+B7-2+/+; n=4), NOD.AireGW/+ mice (AireGW/+ B7-2+/+; n=7),
NOD.B7-2−/− (Aire+/+ B7-2−/−; n=12), or doubly deficient NOD.Aire GW/+ B7-2−/−
(AireGW/+B7-2−/−; n=9) mice. *p<0.001 for all curves compared to B7-2-deficient
NOD.AireGW/+ curve. C) Representative H/E stained, formalin fixed, longitudinal sections
of sciatic nerve from mice of given genotype at time of sacrifice. D) Cumulative infiltration
scores of sciatic nerves from mice of given Aire and B7-2 genotype. Each symbol represents
an individual mouse. *p<0.05 between groups.
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